Nabriva Therapeutics (NBRVF) Q4 2022 Earnings

16MarExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-5
-3.4
-1.79
-0.19

Details

Expected EPS
-4.03
Actual EPS
-4.15
Surprise EPS
-0.12
Surprise Percent
+2.98%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -4.15 per share for Q4 2022.

0 Comments

Share your thoughts